DKSH has launched Hiruscar Anti-Acne Advance Spot Gel – an advanced and improved formulation of its current anti-acne gel product range, further strengthening the brand as a dermatological acne care expert.
Petaling Jaya, Malaysia, April 1, 2022 – DKSH Business Unit Healthcare, a leading partner for healthcare companies seeking to grow their business in Asia and beyond, has launched an advanced formulation of its anti-acne gel product range under its Own Brands, Hiruscar, in Malaysia.
Hiruscar Anti-Acne Advance Spot Gel was specially formulated by Medinova AG, an international pharmaceutical company that provides innovative healthcare solutions to consumers around the world and a member of the DKSH Group. The improved formulation is designed for irritated acne-prone skin and complements Hiruscar’s complete anti-acne range, which includes the Hiruscar Anti-Acne Spot Gel for comedonal acne.
With the addition of Opuntia Ficus-Indica, a type of cactus flower extract that is well-known for exhibiting antioxidant properties as well as Centella Asiatica extract, a unique ingredient with anti-inflammatory qualities, Hiruscar Anti-Acne Advance Spot Gel is clinically proven to be 100% effective in improving irritated acne conditions within 24 hours of application. This extra-strength formulation has also been tested for being non-comedogenic and non-irritating.
Targeted to young adults aged between 18 and 25 years old who experience moderate acne conditions and are unable to find an effective acne treatment solution, Hiruscar Anti-Acne Advance Spot Gel is now available across all pharmacy stores in Malaysia, including independent and chain pharmacies as well as eCommerce platforms, such as Lazada and Shopee.
Gary Chee, Vice President, Healthcare, DKSH Malaysia, said: “Based on the clinical data observed, we are confident that our advanced formulation by Hiruscar can improve the over-the-counter treatment landscape for those who have been heavily affected by irritated acne problems, and through that, we are proud to be staying true to our purpose of enriching people’s lives.”
About DKSH
DKSH’s purpose is to enrich people’s lives. For more than 150 years, we have been delivering growth for companies in Asia and beyond across our Business Units Healthcare, Consumer Goods, Performance Materials, and Technology. As a leading Market Expansion Services provider, we offer sourcing, market insights, marketing and sales, eCommerce, distribution, and logistics as well as after-sales services. Listed on the SIX Swiss Exchange, DKSH operates in 36 markets with 33,100 specialists, generating net sales of CHF 11.1 billion in 2021. The DKSH Business Unit Healthcare distributes pharmaceuticals, consumer health, and over-the-counter (OTC) products as well as medical devices. With around 7,290 specialists, the Business Unit generated net sales of CHF 5.6 billion in 2021. www.dksh.com/hec